About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
https://soho2018.org/
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
DEBATE: Do We Need Maintenance Anti-CD20 Antibody After RCHOP/R-Chemo For Newly Diagnosed Follicular Lymphoma? Pro
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Mathias J. Rummel
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Mathias J. Rummel
106 views
October 25, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Session VIII: Non-Hodgkin Lymphoma
17:19
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Follicular Lymphoma - Bendamustine and Rituximab as Preferred Treatm…
Feat.
M. Rummel
18:05
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Managing High Risk/Relapsed Follicular Lymphoma
Feat.
N. Fowler
16:02
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
DEBATE: Do We Need Maintenance Anti-CD20 Antibody After RCHOP/R-Chem…
Feat.
M. Rummel
12:43
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Advances in the Treatment of Primary Central Nervous System Lymphoma
Feat.
C. Melani
16:44
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
How I Treat Double Hit Lymphoma
Feat.
K. Dunleavy
08:33
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 049: Second Primary Malignancies in T-cell Neoplas…
Feat.
A. Kommalapati
07:40
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 088: Angiogenesis’ Related Polymorphism Emerges as…
Feat.
A. Brito
06:36
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 102: Axicabtagene Ciloleucel in Patients With Refr…
Feat.
S. Neelapu
06:56
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Oral Abstract NHL 122: Durability of Response in Patients With Refra…
Feat.
S. Neelapu
